Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer Analysis

1 Jan 2021

Abstract excerpt

Background: CD161 is a promising immune checkpoint mainly expressed on natural killer (NK) cells and is essential for immunoregulatory functions. However, it remains obscure how CD161 correlates with immune infiltration and patient prognosis in pan-cancer. Methods: We employed HPA, TCGA, GTEx, TIMER2.0, and GEPIA2 databases as well as R language to analyze and visualize CD161 in cancers. Our twenty-four glioma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34659549
DOI: 10.7150/jca.63236

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer AnalysisPMID 34659549Read ↗

Comprehensive pan-cancer analysis identified SLC16A3 as a potential prognostic and diagnostic biomarkerSemantic proximity Read ↗

Prognostic and immunological analysis of METTL16 in pan-cancerSemantic proximity Read ↗

Validating S100A16 as a prognostic and immunological biomarker in pan-cancer and lung adenocarcinoma through integrated Single-cell Sequencing AnalysisSemantic proximity Read ↗

CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus–Driven Oropharyngeal CancerSemantic proximity Read ↗

CD16a<sup>high</sup> NK cell infiltration and spatial relationships with T cells and macrophages can predict improved progression-free survival in high grade ovarian cancerSemantic proximity Read ↗

Increased frequency of CD4+ cells expressing CD161 in cancer patients.Semantic proximity Read ↗

Development and validation of a MUC16 mutation-associated immune prognostic model for lung adenocarcinoma.Semantic proximity Read ↗

Pan-cancer mapping of single T cell profiles reveals a TCF1:CXCR6-CXCL16 regulatory axis essential for effective anti-tumor immunitySemantic proximity Read ↗

Comprehensive Analysis Revealed that CDKN2A is a Biomarker for Immune Infiltrates in Multiple CancersSemantic proximity Read ↗

Identification of SNHG16 and Its Derived Tumor Immune Gene Signatures for Predicting Prognosis and Efficacy of Immunotherapy in Bladder CancerSemantic proximity Read ↗

Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.Semantic proximity Read ↗

Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.